ASPIRIN ENTERIC SAFETY-COATED- aspirin tablet Amerika Syarikat - Inggeris - NLM (National Library of Medicine)

aspirin enteric safety-coated- aspirin tablet

target corporation - aspirin (unii: r16co5y76e) (aspirin - unii:r16co5y76e) - aspirin 81 mg - pain reliever  - for the temporary relief of minor aches and pains or as recommended by your doctor. because of its delayed action, this product will not provide fast relief of headaches or other symptoms needing immediate relief. - ask your doctor about other uses for safety coated 81 mg aspirin

ASPIRIN tablet, delayed release Amerika Syarikat - Inggeris - NLM (National Library of Medicine)

aspirin tablet, delayed release

sunrise pharmaceutical inc - aspirin (unii: r16co5y76e) (aspirin - unii:r16co5y76e) - aspirin 81 mg - pain reliever - for the temporary relief of minor aches and pains or as recommended by your doctor. because of its delayed release action, this product will not provide fast relief of headaches or other symptoms needing immediate relief. if you are allergic to aspirin or any other pain reliever/fever reducer. - stomach bleeding warning applies to you - you have a history of stomach problems, such as heartburn - you have high blood pressure, heart disease, liver cirrhosis, or kidney disease - you are taking a diuretic - you have asthma taking a prescription drug for: - gout - diabetes - arthritis - you experience any of the following signs of stomach bleeding: - feel faint - vomit blood - have bloody or black stools - have stomach pain that does not get better - allergic reaction occurs. seek medical help right away. - pain gets worse or lasts more than 10 days - redness or swelling is present - new symptoms occur - ringing in the ears or loss of hearing occurs

RAZIT 10 rabeprazole sodium 10mg enteric coated tablets, bottles Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

razit 10 rabeprazole sodium 10mg enteric coated tablets, bottles

strides pharma science pty ltd - rabeprazole sodium, quantity: 10 mg - tablet, enteric coated - excipient ingredients: mannitol; titanium dioxide; diacetylated monoglycerides; crospovidone; hypromellose phthalate; light magnesium oxide; ethylcellulose; hyprolose; magnesium stearate; purified talc; heavy magnesium oxide - indicated for: ,? treatment and prevention of relapse of gastro-oesophageal reflux disease ,? symptomatic treatment of gastro-oesophageal reflux disease ,? treatment of duodenal ulcers ,? treatment of gastric ulcers. ,patients whose gastric and duodenal ulceration is not associated with ingestion of non-steroidal anti-inflammatory drugs (nsaids) usually require treatment with antimicrobial agents in addition to antisecretory drugs whether on first presentation or on recurrence. ,also indicated, in combination with clarithromycin and amoxycillin, for: ,? eradication of helicobacter pylori in patients with peptic ulcer disease or chronic gastritis ,? healing of peptic ulcers in patients with helicobacter pylori associated ulcers.

RAZIT 20 rabeprazole sodium 20mg enteric coated tablets, bottles Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

razit 20 rabeprazole sodium 20mg enteric coated tablets, bottles

strides pharma science pty ltd - rabeprazole sodium, quantity: 20 mg - tablet, enteric coated - excipient ingredients: ethylcellulose; titanium dioxide; mannitol; crospovidone; magnesium stearate; iron oxide yellow; diacetylated monoglycerides; heavy magnesium oxide; light magnesium oxide; purified talc; hyprolose; hypromellose phthalate - indicated for: ,? treatment and prevention of relapse of gastro-oesophageal reflux disease ,? symptomatic treatment of gastro-oesophageal reflux disease ,? treatment of duodenal ulcers ,? treatment of gastric ulcers. ,patients whose gastric and duodenal ulceration is not associated with ingestion of non-steroidal anti-inflammatory drugs (nsaids) usually require treatment with antimicrobial agents in addition to antisecretory drugs whether on first presentation or on recurrence. ,also indicated, in combination with clarithromycin and amoxycillin, for: ,? eradication of helicobacter pylori in patients with peptic ulcer disease or chronic gastritis ,? healing of peptic ulcers in patients with helicobacter pylori associated ulcers.